Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- GRAL
- Price
- 99.03
- Stock movement up
- +1.53 (1.57%)
- Company name
- GRAIL, LLC
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Diagnostics & Research
- Market cap
- 3.86B
- Ent value
- 4.09B
- Price/Sales
- 27.22
- Price/Book
- 1.72
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 99.96%
- 1 year return (CAGR)
- 88.34%
- 3 year return (CAGR)
- -
- 5 year return (CAGR)
- -
- 10 year return (CAGR)
- -
Last updated: 2026-03-04
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
GRAL does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 27.22 |
| Price to Book | 1.72 |
| EV to Sales | 28.87 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 38.98M |
| EPS (TTM) | -10.03 |
| FCF per share (TTM) | -7.38 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 147.17M |
| Gross profit (TTM) | -62.57M |
| Operating income (TTM) | -534.16M |
| Net income (TTM) | -408.35M |
| EPS (TTM) | -10.03 |
| EPS (1y forward) | -9.05 |
Margins
Loading...
Margins data
| Gross margin (TTM) | -42.52% |
| Operating margin (TTM) | -362.95% |
| Profit margin (TTM) | -277.47% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 249.73M |
| Net receivables | 18.30M |
| Total current assets | 953.85M |
| Goodwill | 0.00 |
| Intangible assets | 1.85B |
| Property, plant and equipment | 0.00 |
| Total assets | 2.92B |
| Accounts payable | 2.08M |
| Short/Current long term debt | 98.01M |
| Total current liabilities | 79.67M |
| Total liabilities | 344.15M |
| Shareholder's equity | 2.58B |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -299.01M |
| Capital expenditures (TTM) | 1.63M |
| Free cash flow (TTM) | -300.64M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -15.84% |
| Return on Assets | -13.97% |
| Return on Invested Capital | -15.77% |
| Cash Return on Invested Capital | -11.61% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 99.52 |
| Daily high | 101.88 |
| Daily low | 95.17 |
| Daily Volume | 434K |
| All-time high | 116.06 |
| 1y analyst estimate | 88.00 |
| Beta | - |
| EPS (TTM) | -10.03 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 19 Feb 2026 |
Downside potential
Loading...
Downside potential data
| GRAL | S&P500 | |
| Current price drop from All-time high | -14.67% | -1.82% |
| Highest price drop | -61.12% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -22.57% | -10.84% |
| Avg time to new high | 14 days | 12 days |
| Max time to new high | 155 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
3.86B
Marketcap category
Mid-cap
Description
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, it develops minimal residual disease post-diagnostic tests. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
Employees
1000
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page